BackIntegra Lifesciences Holdings Overview

Integra Lifesciences Holdings Total Current Liabilities

Integra Lifesciences Holdings's total current liabilities is $350M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$346.85M

Peer average

Loading

Integra Lifesciences Holdings Total Current Liabilities History

Loading

Integra Lifesciences Holdings vs. peers: Total Current Liabilities Comparison

Loading

Integra Lifesciences Holdings Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Integra Lifesciences Holdings (IART) FAQ

Integra Lifesciences Holdings (IART) currently reports a total current liabilities of $350M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Integra Lifesciences Holdings's total current liabilities history and peer comparisons.

Integra Lifesciences Holdings's total current liabilities changed from $0 to $350M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Integra Lifesciences Holdings reported $350M in total current liabilities as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $350M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Integra Lifesciences Holdings, and consider following IART for alerts when major investors trade the stock.

Integra Lifesciences Holdings is classified in the Healthcare sector. On total current liabilities, it currently shows $350M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IART with unrelated industries.